Poland - Vaccines

Description

The subject of the contract is: Delivery of pneumococcal conjugated vaccine for children; Part: 1÷4The Contracting Authority reserves the right to reduce the purchase of medicinal products, however not by more than 20% of the total subject matter of the order in case the amount allocated for the execution of the order is exceeded or objective and justified needs arise, in particular changes in demand among patients.Pursuant to Article 257 of the PPL Act. The Contracting Authority shall have the right to cancel the public procurement procedure if the funds that he intended to use for financing the whole or part of the contract were not granted to him.
Supply of 100 000 doses of pneumococcal conjugate vaccine1. Pursuant to Article 105 and Article 106 of the PPL Act, in order to confirm the compliance of the offered supplies with the requirements of the Public Procurement Law, the Applicant shall submit the following documents to confirm compliance of the supplies offered with the requirements, features or criteria specified in the description of the subject matter of the contract or with the evaluation criteria for the tenders or the requirements connected with the performance of the contract, the Contracting Authority shall require contractors to present:- a valid, up-to-date marketing authorisation for the medicinal product in the territory of the Republic of Poland issued by the President of the Office for Registration of Medicinal Products, Medical Devices and Biocidal Products,or- a valid, up-to-date marketing authorisation for the medicinal product issued by the Council of the European Union or the European Commission,1.(2) Pursuant to Article 107(1) of the PPL Act, the Economic Operator shall submit the above mentioned means of evidence together with the tender.1.3 The marketing authorization for the medicinal product must be valid and current as of the date of submission of the tender.1.4 The composition of the preparation and the packaging must comply with the content of the documents referred to in item 1.1.1.5 If the validity of the document expires, the Contractor shall submit to the Contracting Authority, together with the documents referred to in item 1.1, an additional document declaring that an application for renewal of the marketing authorisation for the medicinal product has been submitted in due time or, if granted, a valid marketing authorisation for the medicinal product.1.6 The aforementioned documents shall be valid for the entire period of performance of the contract.1.7 The documents referred to above shall be submitted in the manner prescribed in regulations issued pursuant to Article 70 of the PPL Act.1.8 The Contracting Authority, pursuant to Article 107, paragraph 2 of the PPL Act, shall provide for the possibility of supplementing the aforementioned means of evidence once.1.9 Documents prepared in a foreign language shall be submitted with a translation into Polish. Supply of 200,000 doses of pneumococcal conjugate vaccine1. Pursuant to Article 105 and Article 106 of the PPL Act, in order to confirm the compliance of the supplies offered with the requirements of the Public Procurement Law, the Applicant shall submit the following documents to confirm compliance of the supplies offered with the requirements, features or criteria specified in the description of the subject matter of the contract or with the evaluation criteria for the tenders or the requirements connected with the performance of the contract, the Contracting Authority shall require contractors to present:- a valid, up-to-date marketing authorisation for the medicinal product in the territory of the Republic of Poland issued by the President of the Office for Registration of Medicinal Products, Medical Devices and Biocidal Products,or- a valid, up-to-date marketing authorisation for the medicinal product issued by the Council of the European Union or the European Commission,1.(2) Pursuant to Article 107(1) of the PPL Act, the Economic Operator shall submit the above mentioned means of evidence together with the tender.1.3 The marketing authorization for the medicinal product must be valid and current as of the date of submission of the tender.1.4 The composition of the preparation and the packaging must comply with the content of the documents referred to in item 1.1.1.5 If the validity of the document expires, the Contractor shall submit to the Contracting Authority, together with the documents referred to in item 1.1, an additional document declaring that an application for renewal of the marketing authorisation for the medicinal product has been submitted in due time or, if granted, a valid marketing authorisation for the medicinal product.1.6 The aforementioned documents shall be valid for the entire period of performance of the contract.1.7 The documents referred to above shall be submitted in the manner prescribed in regulations issued pursuant to Article 70 of the PPL Act.1.8 The Contracting Authority, pursuant to Article 107, paragraph 2 of the PPL Act, shall provide for the possibility of supplementing the aforementioned means of evidence once.1.9 Documents prepared in a foreign language shall be submitted with a translation into Polish. Supply of 200,000 doses of pneumococcal conjugate vaccine1. Pursuant to Article 105 and Article 106 of the PPL Act, in order to confirm the compliance of the supplies offered with the requirements of the Public Procurement Law, the Applicant shall submit the following documents to confirm compliance of the supplies offered with the requirements, features or criteria specified in the description of the subject matter of the contract or with the evaluation criteria for the tenders or the requirements connected with the performance of the contract, the Contracting Authority shall require contractors to present:- a valid, up-to-date marketing authorisation for the medicinal product in the territory of the Republic of Poland issued by the President of the Office for Registration of Medicinal Products, Medical Devices and Biocidal Products,or- a valid, up-to-date marketing authorisation for the medicinal product issued by the Council of the European Union or the European Commission,1.(2) Pursuant to Article 107(1) of the PPL Act, the Contractor shall submit the aforementioned evidence together with the tender.1.3 The marketing authorization for the medicinal product must be valid and current as of the date of submission of the tender.1.4 The composition of the preparation and the packaging must comply with the content of the documents referred to in item 1.1.1.5 If the validity of the document expires, the Contractor shall submit to the Contracting Authority, together with the documents referred to in item 1.1, an additional document declaring that an application for renewal of the marketing authorisation for the medicinal product has been submitted in due time or, if granted, a valid marketing authorisation for the medicinal product.1.6 The aforementioned documents shall be valid for the entire period of performance of the contract.1.7 The documents referred to above shall be submitted in the manner prescribed in regulations issued pursuant to Article 70 of the PPL Act.1.8 The Contracting Authority, pursuant to Article 107, paragraph 2 of the PPL Act, shall provide for the possibility of supplementing the aforementioned means of evidence once.1.9 Documents prepared in a foreign language shall be submitted with a translation into Polish. Supply of 200,000 doses of pneumococcal conjugate vaccine1. Pursuant to Article 105 and Article 106 of the PPL Act, in order to confirm the compliance of the supplies offered with the requirements of the Public Procurement Law, the Applicant shall submit the following documents to confirm compliance of the supplies offered with the requirements, features or criteria specified in the description of the subject matter of the contract or with the evaluation criteria for the tenders or the requirements connected with the performance of the contract, the Contracting Authority shall require contractors to present:- a valid, up-to-date marketing authorisation for the medicinal product in the territory of the Republic of Poland issued by the President of the Office for Registration of Medicinal Products, Medical Devices and Biocidal Products,or- a valid, up-to-date marketing authorisation for the medicinal product issued by the Council of the European Union or the European Commission,1.(2) Pursuant to Article 107(1) of the PPL Act, the Contractor shall submit the aforementioned evidence together with the tender.1.3 The marketing authorization for the medicinal product must be valid and current as of the date of submission of the tender.1.4 The composition of the preparation and the packaging must comply with the content of the documents referred to in item 1.1.1.5 If the validity of the document expires, the Contractor shall submit to the Contracting Authority, together with the documents referred to in item 1.1, an additional document declaring that an application for renewal of the marketing authorisation for the medicinal product has been submitted in due time or, if granted, a valid marketing authorisation for the medicinal product.1.6 The aforementioned documents shall be valid for the entire period of performance of the contract.1.7 The documents referred to above shall be submitted in the manner prescribed in regulations issued pursuant to Article 70 of the PPL Act.1.8 The Contracting Authority, pursuant to Article 107 par. 2 of the PPL Act, shall provide for the possibility to supplement the aforementioned means of evidence once.1.9 Documents written in a foreign language shall be submitted with a translation into Polish.

Opportunity closing date

18 June 2021

Value of contract

to be confirmed